• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. public health

public health

Page 54 of 86

AstraZeneca coronavirus
Health

AstraZeneca stock slips on mixed earnings report and coronavirus uncertainty

By Sy Mukherjee
February 14, 2020
In business vs. coronavirus, coronavirus is winning
Magazine

In business vs. coronavirus, coronavirus is winning

By Erika Fry
February 13, 2020
What health insurance doesn’t cover
Newsletters

What health insurance doesn’t cover

By Sy Mukherjee
February 12, 2020
Coronavirus mask medical supply chain
Newsletters

How coronavirus panic is making virus containment more difficult

By Sy Mukherjee
February 7, 2020
Nestle Aimmune Peanut Allergy Drug
Newsletters

Nestlé invests another $200 million in Aimmune’s peanut allergy drug

By Sy Mukherjee
February 6, 2020
Gates Foundation Coronavirus Donation
Health

The Gates Foundation is pledging up to $100 million for the fight against coronavirus

By Sy Mukherjee
February 5, 2020
Coronavirus vaccine development
Health

The first coronavirus drug candidate is set for testing in China

By Sy Mukherjee
February 3, 2020
Wuhan coronavirus transmission
Health

How the Wuhan coronavirus spreads and what’s being done about it

By Sy Mukherjee
January 30, 2020
Bloomberg Drug Prices
Newsletters

One drug, one patent?

By Sy Mukherjee
January 29, 2020
Kobe Bryant Death Science of Grief
Newsletters

Kobe Bryant and the science of grief

By Sy Mukherjee
January 28, 2020
China Coronavirus Vaccine
Newsletters

The hunt for a coronavirus vaccine begins

By Sy Mukherjee
January 24, 2020
China coronavirus U.S. case CDC
Newsletters

The CDC says the deadly coronavirus from China has now come to the U.S.

By Sy Mukherjee
January 22, 2020
Most Active States CDC
Newsletters

The most active states in America

By Sy Mukherjee
January 17, 2020
China Mystery Illness
Newsletters

Insight Into a Mystery Illness in China

By Sy Mukherjee
January 10, 2020
Vaping E-Cig Lung Respiratory Illness Study
Newsletters

A New Study Shows the Damage Just 3 Years of Vaping Could Do to Your Lungs

By Sy Mukherjee
December 16, 2019

Most Popular

  • Success
    Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
    By Nick Lichtenberg
  • Success
    Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
    By Dave Smith
  • AI
    AI engineers are being deployed as consultants and getting paid $900 per hour
    By Nino Paoli
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.